Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No news or updates. For one.
Why is there weak volume?
Conspiracy theories too??
That’s not accurate. Share price is here around the $4.00 range because of the weak volume. No one is purposely tanking the share price. If they wanted to tank it it would be much lower
I believe, in my opinion, that this is exactly what is going to happen. They can make themselves whole on the other end
Yea I mean if they wanted to hold or grow the SP the billionaires are smart enough to do so with some PR’s or company updates. There’s some scheme lined up to buy the cheapies and possibly even wipe out current investors. Armen Jay and Charles are crooks!
" They are purposely tanking the SP. " yep , many people feel the same , dont know why they want to do that . If Mars still CEO here things could be lots different, pps at least $0.20 something before the stupid RS .
Management doesn’t care about their shareholders. They are purposely tanking the SP. Armen, Jay, Charles. They all SUCK!!!
Agreed. Another bull market RXMD failed to capitalize on. I do declare, I definitely have more petty cash in my Levi's than the dollar value of shares traded so far today. =)
Next to zero interest here, carrots dangle; but no one buying the mystery of Fernandez's self promoting plans of wizardy for RXMD. The jig is up Chucky, shareholders deserve a more communicative CEO, RXMD already had a bump on a log when Jay was at the helm.
Good luck all, it like 30 seconds remaining on the Silent Fernandez play clock with RXMD in need of a major hail mary to allow longs the ability to at least break even.
I mean this is just honestly sad…. Biggest run on market over the last couple months that we have had since the COVID bs, and we are sitting 50% down in the last 6 months
Yes, unless they are going to announce merger , RXMD'ans should not get excited.
Losing key employees under newly appointed CEO certainly doesn't help RXMD. What's the logic on highlighting that?
Nor does month after month of silence from CEO Fernandez since taking over from Jay in November. RXMD was once a shareholder friendly company, those days are long gone. Most shareholders down about 50% since sneaky RS.
Yup! All major indexes hitting 52 weeks highs, RXMD.... not so much.
Glad I dumped this stagnant stock and got into others that are actually increasing my wealth, unlike this company.
Tick tock..... Thanks SF
Bring it!!! Soooo ready!
In 19 days, Progressive Care’s CFO, Cecile Munnik, will become NextPlat’s full time CFO. She’s currently only spending 30% of her time at NextPlat according to her employment agreement. July 1 seems to be a predetermined date that the company will announce some major news.
Robert Bedwell is currently a FULL Time (Note not part time like CFO Cecille Munnik) Chief Compliance Officer of NextPlat. There was no such a position at the company before. His current full time title at Progressive Care is Director of Administrative Services.
"DO YOU NEED TO HIRE A COMPLIANCE OFFICER?
Now you know what they do, but what is a compliance officer to your business? How can you tell if you need one of these professionals? The answer isn’t always straightforward, but there are some factors to consider when deciding whether to hire a compliance officer.
First, evaluate your company’s size. How many employees do you have? Where do you stand in your industry’s market? Have you grown significantly in recent years? These are all questions that can help you decide if you need a full-time compliance officer.
Smaller businesses may not need a dedicated compliance officer, but larger companies with complex operations and more employees could benefit from their guidance. Here are some other factors to consider:
YOUR INDUSTRY
Your industry should be one of the first considerations you make. This is because companies operating in heavily regulated industries often face a significant compliance burden, and those burdens can be hard to manage without professional help.
By hiring a full-time compliance officer with industry-specific expertise, businesses can ensure they meet all necessary requirements, mitigate risks, and avoid the potential legal and financial consequences that accompany non-compliance.
Examples of heavily regulated industries include:
Oil and gas
Healthcare
Finance
Construction"
https://insightglobal.com/blog/does-your-company-need-a-compliance-officer/
Now we know why NextPlat paid $125,000 to Bedwell to hire him as a CCO. This is because healthcare will be the core business of NextPlat.
https://contracts.justia.com/companies/orbital-tracking-corp-1828/contract/260160/
How about the fact that we are still down almost 50% since the massive RS, with very little information from the people running the show? Don’t have to look for that, it is slapping us all in the face daily
Absolutely correct gedi. Some ppl just look for something to b itch about.
Just my point. The stock price has been bouncing around lately
Not at the time I posted
Thanks again, SF... Excellent information...
Watch and Learn ....about RXMD....
How ridiculous.
Actually RXMD was up yesterday and up again so far today.
"Why Healthcare Should Adopt Merchandising Practices
June 5, 2023
Healthcare has gone through several evolutions throughout the course of human history. Our first attempts at treating medical conditions were half-hearted at best and hampered by our ignorance of germ theory and human biology. The acceptance of germ theory paved the way for modern healthcare and allowed humanity to treat previously fatal injuries and conditions, extending our lifetimes and giving people much longer lifespans.
The medical field continued to develop in tandem with technology, adapting more and more complex technology into the field to enhance research and develop a wide variety of medications.
With the internet and e-commerce now entrenched in modern society, the healthcare sector is now going through another evolution.
Long gone are the days when you had to physically visit your local doctor or pharmacy to receive medical care or prescribed treatments. The internet has made it possible for patients to interact with healthcare specialists from the comfort of their homes and allowed clinicians to access medical information as soon as they need it.
Major e-commerce companies such as Amazon are now throwing their hats into the healthcare arena by making it possible for patients to easily purchase medications they need online. Although some experts have questioned the entry of such entities into healthcare, the sector itself could benefit from adopting the merchandising practices that made online commerce companies such as Amazon so successful.
They could do this by making healthcare access as simple and streamlined as online commerce.
Setting up a doctor appointment can be incredibly frustrating (80% of patients give up before booking an appointment), and it wastes a lot of time that could have been spent consulting with healthcare professionals and getting to the root of your medical issues. If the healthcare sector leverages the technology used in e-commerce, finding a suitable healthcare professional could be as simple as logging into your favorite e-commerce site, searching for the products you need, adding them to your cart and clicking “buy.”
Following the e-commerce system, patients would make a search on a specific website or a search engine that would direct them to the healthcare system’s booking system, which would filter results based on patient’s needs and intentions. The system would then show patients available options in real time while providing pertinent information such as the specialties, prices, locations, and availability of providers.
Such a system would save time for patients while allowing them to connect with the most suitable physicians with relatively little hassle.
The mushrooming of ecommerce platforms such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) will undoubtedly help to push the envelope of what is possible for healthcare ecommerce and the adaption of merchandising principles within healthcare."
https://www.biomedwire.com/why-healthcare-should-adopt-merchandising-practices/
"With Amazon welcoming partnerships with a variety of healthcare ecommerce platform providers such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW), the way people access different services related to healthcare could be set for a major transformation over the coming years."
May 30, 2023
NextPlat is an IBN CORE Client. The Market Awareness Profile data is approved & verified by the issuer.
https://www.biomedwire.com/amazons-5-monthly-plan-to-deepen-giants-foray-into-healthcare-ecommerce/
And we are down again with no volume
Will NextPlat have an opportunity to form health e-commerce platform partnership with Amazon? Is this unthinkable or actually doable?
Well it’s up again with volume today.
It does to those who are invested in both. ))
Yup. But I don’t think the share price of nxpl matters to rxmd shareholders until after the shares transfer…. It going up now doesn’t help us
It’s also possible that Rx reverse merges into nextplat and is the surviving company with the emphasis now on moving to digital healthcare and spinning off the sats. No one knows til something happens.
As usual.
Don’t think share price at time of merger matters for rxmd stockholders, but we shall see
We can disagree on that. If there was some sort of merger then NXPL and RXMD share price is very important.
Who cares. Doesn’t help us
Money Money Money coming gedi. It might (definitely is) be a little longer than any of us expected, but I'm definitely more confident today than I was 12/31/2022.
Yes...NXPL up 13% right now on 15,000 shares traded
NXPL volume and share price up this morning.
Dr Fernandez is doing major surgery behind closed doors to make this into a beautiful butterfly
Well said, my friend. Nothing going on here, RS and Fernandez killed all potential momentum.
I believe Big Daddy Kane summarized RXMD leadership practices best, "So put a quarter in your azz 'cause you played yourself" LOL
Quickly approaching 8 months of silence from new CEO appointed back in November, this guy is pathetic. Both companies this CEO is leading have declining PPS, stagnant price action and low interest from potential investors.
So many better investments out there, the hope and waiting game on RXMD isn't worth waiting, markets are hot, RXMD is not.
I'm still in here. Just some song lyrics of John Lennon.
Looks like you have about 4-6 months to get back in, probably at a lower price.
No longer riding on the merry go round, I just had to let it go
Followers
|
745
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
194800
|
Created
|
01/09/11
|
Type
|
Free
|
Moderators gedi8 Truth022809 stockforce TrackDude MrMike241 |
Progressive Care Gains SEC Reporting Status
See on website
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
PRODUCTS AND SERVICES
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
concerns
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications
PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
1. On time, same day deliveries available twice a day with 24 hour emergency support
2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
3. Unit-dose packaging options tailored the facility's needs
4. Prescription data accuracy
5. Extensive medication and DME inventory
6. Access to OTC medications, nutritional products and personal hygiene items
7. Provision and review of medication carts
8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
9. Compliance updates and consultations
10. Staff Training
11. Exceptional customer service.
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
HOURS
Monday- Thursday 8:30 AM - 6:30 PM
Friday 8:30 AM - 6:00 PM
Saturday 11:00 AM - 4:00 PM
PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in RevenueGLOBENEWSWIRE – 11:16 AM ET 03/29/2022 |
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in ChinaGLOBENEWSWIRE – 7:00 AM ET 02/02/2022
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |